MKC
48
-9
BWA
21
-7
PCAR
30
-4
DD
15
-11
WAT
30
-7
REGN
23
-7
VTR
40
-15
GILD
60
-9
EW
20
-16
FITB
43
-6
PNR
32
-7
FLR
30
-10
SE
41
-16
MU
32
-3
TRIP
16
-13
BF.B
35
-7
CA
13
-3
LEG
20
-5
EMC
1
-8
GOOG
20
-26
MKC
48
-9
BWA
21
-7
PCAR
30
-4
DD
15
-11
WAT
30
-7
REGN
23
-7
VTR
40
-15
GILD
60
-9
EW
20
-16
FITB
43
-6
PNR
32
-7
FLR
30
-10
SE
41
-16
MU
32
-3
TRIP
16
-13
BF.B
35
-7
CA
13
-3
LEG
20
-5
EMC
1
-8
GOOG
20
-26
Financhill
Back

Verona Pharma PLC Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31

VRNA
Verona Pharma PLC

Last Price:
$53.91
Seasonality Move:
-8.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRNA is experiencing slight selling pressure.

Verona Pharma PLC Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 60.71 Sell
20-day SMA: 63.48 Sell
50-day SMA: 62.16 Sell
200-day SMA: 39.02 Buy
8-day EMA: 59.84 Sell
20-day EMA: 62.23 Sell
50-day EMA: 60.17 Sell
200-day EMA: 43.37 Buy

Verona Pharma PLC Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 34.6 Sell
Chaikin Money Flow: -940585 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.74 - 67.72) Sell
Bollinger Bands (100): (41.34 - 63.14) Buy

Verona Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Verona Pharma PLC Stock

Is Verona Pharma PLC Stock a Buy?

  • Verona Pharma PLC share price is 53.90 while VRNA 8-day simple moving average is 60.71, which is a Sell signal.
  • The stock price of VRNA is 53.90 while Verona Pharma PLC 20-day SMA is 63.48, which makes it a Sell.
  • Verona Pharma PLC 50-day simple moving average is 62.16 while VRNA share price is 53.90, making it a Sell technically.
  • VRNA stock price is 53.90 and Verona Pharma PLC 200-day simple moving average is 39.02, creating a Buy signal.

VRNA Technical Analysis vs Fundamental Analysis

Sell
31
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC a Buy or a Sell?

  • Verona Pharma PLC stock is rated a Sell
    The current Verona Pharma PLC [VRNA] share price is $53.90. The Score for VRNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.

Verona Pharma PLC Stock Info

Market Cap:
4.6B
Price in USD:
53.90
Share Volume:
2.1M

Verona Pharma PLC 52-Week Range

52-Week High:
70.40
52-Week Low:
11.39
Sell
31
Verona Pharma PLC (VRNA) is a Sell

Verona Pharma PLC Share Price Forecast

Is Verona Pharma PLC Stock a Buy?

  • Verona Pharma PLC share price is 53.90 while VRNA 8-day exponential moving average is 59.84, which is a Sell signal.
  • The stock price of VRNA is 53.90 while Verona Pharma PLC 20-day EMA is 62.23, which makes it a Sell.
  • Verona Pharma PLC 50-day exponential moving average is 60.17 while VRNA share price is 53.90, making it a Sell technically.
  • VRNA stock price is 53.90 and Verona Pharma PLC 200-day simple moving average is 43.37, creating a Buy signal.

Fundamental Analysis of Verona Pharma PLC

Is Verona Pharma PLC a good investment?

  • Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.03 per share, an increase this year of $1.45 per share, and an increase next year of $0.25 per share.

Technical Analysis of Verona Pharma PLC

Should I short Verona Pharma PLC stock?

* Verona Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.